| __timestamp | AstraZeneca PLC | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 104381000 |
| Thursday, January 1, 2015 | 5997000000 | 100171000 |
| Friday, January 1, 2016 | 5890000000 | 102726000 |
| Sunday, January 1, 2017 | 5757000000 | 96171000 |
| Monday, January 1, 2018 | 5932000000 | 66449000 |
| Tuesday, January 1, 2019 | 5958000000 | 42672000 |
| Wednesday, January 1, 2020 | 5991000000 | 42534000 |
| Friday, January 1, 2021 | 9736000000 | 53311000 |
| Saturday, January 1, 2022 | 9762000000 | 82258000 |
| Sunday, January 1, 2023 | 10935000000 | 118011000 |
| Monday, January 1, 2024 | 13583000000 |
Data in motion
In the ever-evolving landscape of pharmaceutical research, AstraZeneca PLC and Celldex Therapeutics, Inc. stand as intriguing case studies. Over the past decade, AstraZeneca has consistently invested in research and development, with expenditures peaking at approximately $10.9 billion in 2023, marking a 96% increase from 2014. This commitment underscores AstraZeneca's strategic focus on innovation and growth.
Conversely, Celldex Therapeutics, a smaller player, has shown a more modest R&D investment trajectory. In 2023, their R&D expenses reached around $118 million, reflecting a 13% increase from 2014. Despite the disparity in scale, Celldex's focused investments highlight their dedication to niche therapeutic areas.
This comparison not only illustrates the diverse strategies within the pharmaceutical industry but also emphasizes the critical role of R&D in driving medical advancements and competitive positioning.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for AbbVie Inc. and AstraZeneca PLC
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Amgen Inc.
Comparing Innovation Spending: AstraZeneca PLC and Dr. Reddy's Laboratories Limited
R&D Spending Showdown: AstraZeneca PLC vs Pharming Group N.V.
AstraZeneca PLC vs Ionis Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: AstraZeneca PLC vs Xenon Pharmaceuticals Inc.
AstraZeneca PLC and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
PTC Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Galapagos NV vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Celldex Therapeutics, Inc. vs Novavax, Inc.
Research and Development Investment: Celldex Therapeutics, Inc. vs Evotec SE